A panel of phenotypically and genotypically diverse bioluminescent:fluorescent Trypanosoma cruzi strains as a resource for Chagas disease research.
Francisco OlmoShiromani JayawardhanaArchie A KhanHarry C LangstonAmanda Fortes FranciscoRichard L AthertonAlex I WardMartin C TaylorJohn M KellyMichael D LewisPublished in: PLoS neglected tropical diseases (2024)
Chagas disease is caused by Trypanosoma cruzi, a protozoan parasite that displays considerable genetic diversity. Infections result in a range of pathological outcomes, and different strains can exhibit a wide spectrum of anti-parasitic drug tolerance. The genetic determinants of infectivity, virulence and therapeutic susceptibility remain largely unknown. As experimental tools to address these issues, we have generated a panel of bioluminescent:fluorescent parasite strains that cover the diversity of the T. cruzi species. These reporters allow spatio-temporal infection dynamics in murine models to be monitored in a non-invasive manner by in vivo imaging, provide a capability to detect rare infection foci at single-cell resolution, and represent a valuable resource for investigating virulence and host:parasite interactions at a mechanistic level. Importantly, these parasite reporter strains can also contribute to the Chagas disease drug screening cascade by ensuring that candidate compounds have pan-species in vivo activity prior to being advanced into clinical testing. The parasite strains described in this paper are available on request.
Keyphrases
- trypanosoma cruzi
- escherichia coli
- genetic diversity
- single cell
- pseudomonas aeruginosa
- staphylococcus aureus
- biofilm formation
- quantum dots
- emergency department
- high resolution
- crispr cas
- antimicrobial resistance
- gene expression
- toxoplasma gondii
- genome wide
- rna seq
- cystic fibrosis
- high throughput
- type diabetes
- label free
- dna methylation
- mass spectrometry
- insulin resistance